Plasma cytokeratin‐18 concentrations as noninvasive biomarker of early gastrointestinal toxicosis in dogs receiving toceranib

BACKGROUND: No biomarkers for the early detection of gastrointestinal (GI) toxicosis secondary to antineoplastic treatment are recognized in veterinary medicine. Toceranib causes GI toxicosis in dogs. HYPOTHESIS/OBJECTIVE: To assess if changes in plasma cytokeratin 18 (CK18) concentration, measured...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovac, Rachel L., Ballash, Gregory, Fenger, Joelle, London, Cheryl, Warry, Emma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271317/
https://www.ncbi.nlm.nih.gov/pubmed/30353992
http://dx.doi.org/10.1111/jvim.15326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271317/
https://www.ncbi.nlm.nih.gov/pubmed/30353992
http://dx.doi.org/10.1111/jvim.15326

Ejemplares similares